Forge Biologics, Author at Forge Biologics - Page 4 of 12

Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

Forge Biologics Fuels Gene Therapy Manufacturing Engine with Launch of Plasmid DNA Manufacturing Services to Support AAV Clients

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics Fuels Gene Therapy Manufacturing Engine with Launch of Plasmid DNA Manufacturing Services┬áto Support AAV Clients

Forge Biologics Announces $90 Million Series C Financing to Expand Client Offerings and Add Services to Enhance End-to-End Gene Therapy Manufacturing Platforms

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics Announces $90 Million Series C Financing to Expand Client Offerings and Add Services to Enhance End-to-End Gene Therapy Manufacturing Platforms